Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yiqi Jianpi Oral Solution (益气健脾口服液) is a traditional Chinese medicine (TCM) formulation developed and marketed by ApicHope Pharmaceuticals (formerly known as Yipinhong Pharmaceutical). It is an over-the-counter (OTC) pediatric medication administered orally. The product is designed to 'tonify qi and strengthen the spleen' (Yiqi Jianpi), a TCM therapeutic principle typically applied to address pediatric digestive health, poor appetite, and general wellness. As a TCM product, it consists of a complex mixture of herbal extracts rather than a single active pharmaceutical ingredient, and it is part of ApicHope's specialized portfolio of children's medications in the Chinese market.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yiqi Jianpi Oral Solution.